BC Innovations | Nov 4, 2019
Distillery Therapeutics

Dual TLR7 and TLR8 agonism for pancreatic cancer

DISEASE CATEGORY: Cancer INDICATION: Pancreatic cancer Agonizing stromal TLR7 and TLR8 could treat pancreatic ductal adenocarcinoma (PDAC). In mice with PDAC, a TLR7 and TLR8 agonist tool compound reduced tumor growth and hallmarks of cachexia,...
BC Innovations | Aug 24, 2017
Product R&D

MedImmune's neo stimulus package

The MedImmune LLC unit of AstraZeneca plc thinks its pipeline of immune stimulators will give it an edge in the crowded field of neoantigen cancer vaccines. The company's strategy raises the question of whether the...
Items per page:
1 - 2 of 2